Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for October, 2009

PPD puts skin in the game with Celtic alliance

Friday, October 30th, 2009

The typical CRO/sponsor relationship can be prone to delays as a result of the way trials are set up or misunderstandings between the parties. PPD is looking to avoid such delays by bringing products to market more quickly with its recent agreement to invest $100 million in Celtic Therapeutics Holdings ...

Roche eyes new talent for Jersey makeover

Wednesday, October 28th, 2009

Roche is looking for a few good cellular biologists. More than a few, to be exact. The pharma giant has launched an ambitious recruitment campaign to add research muscle to its transforming R&D campus in Nutley, N.J., the former site of Roche’s U.S. commercial operations, since whisked off to South ...

More proof of vaccine boom

Monday, October 26th, 2009

In case you missed it, the World Health Organization released a comprehensive new vaccines report late last week, its unveiling no doubt timed with the uptick in swine flu immunization campaigns around the world (read the latest on H1N1 vaccine supply shortages here.) Here’s the WHO press release on the study. ...

Lupus drought: 50 years and counting

Thursday, October 8th, 2009

In this month’s issue of R&D Directions, we examine the 10 most active areas of therapeutic research, and also highlight some promising therapies for diseases in these categories. One condition researchers are particularly hesitant to lump into that “promising” group is lupus – and who could blame them? There have ...

Progress made as search for breast cancer cure continues

Wednesday, October 7th, 2009

Since October is Breast Cancer Awareness Month, I thought it would be appropriate to bring attention to some recent news and findings in the field. A researcher from Northwestern University Feinberg School of Medicine has found a way to strengthen the breast’s protective barriers to prevent cancer from metastasizing. The researcher found ...

Quintiles increases clinical trial awareness

Friday, October 2nd, 2009

With the lack of participation in clinical trials being one of the major factors in delaying the development of new drugs, Quintiles has launched a new Website in hopes of encouraging patients to be more active in bringing new drugs to market faster. The company cites research that shows that ...

   
©2012 UBM Canon